secwatch.observer — SEC 8-K summary
======================================

Issuer:     Syra Health Corp (SYRA)
CIK:        0001922335
Form:       8-K
Filed at:   2026-05-07T23:59:59+00:00
Accession:  0001493152-26-021629
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Syra Health posts first profitable quarter in Q1 2026; net income $241K, EPS $0.02, revenue up 22%
--------------------------------------------------------------------------------

- Net income of $241,000 vs net loss of $(472,265) in Q1 2025; EPS $0.02 vs ($0.04).
- Total revenue $2.3M (+22% YoY); population health solutions grew 46% to $1.8M.
- Gross margin expanded to 42.7%, up 11 ppt from 31.7%.
- Cash on hand $2.9M; no long-term debt as of March 31, 2026.
- Adjusted EBITDA improved to $244,495 from $(462,239) in prior year.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1922335/000149315226021629/0001493152-26-021629-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1922335/000149315226021629/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-021629

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer